EGRASS helps prepare and fortify critical structures to protect against the worst consequences of new hurricanes.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

Top scientists and officials from government, academia, Alaskan Native communities, and industry are heading to Alaska to focus on driving energy technologies for a more sustainable Arctic region.

Sue Southard's one thousand dives as a PNNL staff member leave a ripple effect on efforts to keep our ocean healthy, our economy thriving, and our waters safe.

Researchers use machine learning to speed up the analysis of aerosol datasets from mass spectrometry.

Brian O’Neill joins a Roundtable on climate security organized by the National Academies of Sciences, Engineering, and Medicine.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Business Interns Maryam Masood and Eden Yonas presented a framework for building a better discourse around climate change and environmental justice at the Battelle Conference on Innovations in Climate Resilience.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

PNNL experts perform fundamental climate science work at multiple scales to understand impacts on energy, water, food, and infrastructure systems.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Mowei Zhou, a chemist with the Environmental Molecular Sciences Laboratory, is speaking at the ACS spring conference on his latest protein discoveries for a plant that could transform biofuels production.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

In adjoining Energy Sciences Center laboratories, researchers develop better energy storage devices by understanding the fundamental reactions that form interfaces.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.